Thrombus formation after left atrial appendage exclusion using an amplatzer cardiac plug device

被引:36
作者
Cruz-Gonzalez, Ignacio [1 ]
Martin Moreiras, Javier [1 ]
Garcia, Eulogio [2 ]
机构
[1] Univ Hosp Salamanca, Div Cardiol, Salamanca 37007, Spain
[2] Hosp Clin San Carlos, Div Cardiol, Madrid, Spain
关键词
complications adult cath/intervention (COMP); left arterial appendage closure (LAC); thrombus; TRANSCATHETER CLOSURE; SEPTAL-DEFECT; PREVENTION; FIBRILLATION; PATIENT; STROKE;
D O I
10.1002/ccd.23126
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The feasibility and safety of left atrial appendage closure with the Amplatzer cardiac plug (AGA Medical Corp., Minneapolis, MN) have been recently published; no thrombus formation on the device surface has been reported previously. We describe a case of a 66-year-old man with permanent atrial fibrillation, previous stroke, and contraindication for long-term oral anticoagulant therapy. A 22-mm ACP device was deployed successfully without complications. The patient was discharged on acetyl salicylic acid 100 mg and clopidogrel 75 mg daily. After 4 weeks, the patient was admitted for a lower gastrointestinal bleeding and clopidogrel was stopped. A 3-month follow-up echocardiogram confirmed the exclusion of the LAA but it demonstrated the presence of a thrombus on the atrial surface of the device. It was decided to keep the patient on acetyl salicylic acid 100 mg with the addition of enoxaparin 60 mg bid. Transesophageal echocardiogram demonstrated total resolution of the thrombus after 2 months. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:970 / 973
页数:4
相关论文
共 15 条
[1]   Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices [J].
Anzai, H ;
Child, J ;
Natterson, B ;
Krivokapich, J ;
Fishbein, MC ;
Chan, VK ;
Tobis, JM .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (04) :426-431
[2]  
Bayard Yves L, 2005, Expert Rev Cardiovasc Ther, V3, P1003, DOI 10.1586/14779072.3.6.1003
[3]   Surgical removal of atrial septal defect occlusion system-devices [J].
Bohm, J ;
Bittigau, K ;
Kohler, F ;
Baumann, G ;
Konertz, W .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 12 (06) :869-872
[4]   Left Atrial Appendage Exclusion: State-Of-The-Art [J].
Cruz-Gonzalez, Ignacio ;
Yan, Bryan P. ;
Lam, Yat-Yin .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 75 (05) :806-813
[5]  
Gastmann O, 1998, CATHETER CARDIO DIAG, V43, P81, DOI 10.1002/(SICI)1097-0304(199801)43:1<81::AID-CCD24>3.3.CO
[6]  
2-F
[7]   Editorial comment - Obliteration of the left atrial appendage for prevention of thromboembolism [J].
Halperin, JL ;
Gomberg-Maitland, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) :1259-1261
[8]   Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial [J].
Holmes, David R. ;
Reddy, Vivek Y. ;
Turi, Zoltan G. ;
Doshi, Shephal K. ;
Sievert, Horst ;
Buchbinder, Maurice ;
Mullin, Christopher M. ;
Sick, Peter .
LANCET, 2009, 374 (9689) :534-542
[9]   Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients [J].
Krumsdorf, U ;
Ostermayer, S ;
Billinger, K ;
Trepels, T ;
Zadan, E ;
Horvath, K ;
Sievert, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (02) :302-309
[10]   Patent foramen ovale transcatheter closure device thrombosis [J].
Nkomo, VT ;
Theuma, P ;
Maniu, CV ;
Chandrasekaran, K ;
Miller, FA ;
Schaff, HV ;
Petty, GW ;
Miller, TD .
MAYO CLINIC PROCEEDINGS, 2001, 76 (10) :1057-1061